Search

everythinglearnresearchcommunity

for

Search:↓

Hair structure worsens as tumors grow in mice.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Lavender oil use in a child may be linked to early puberty signs and elevated tumor marker levels.

Lack of vitamin D receptor increases skin tumor risk by boosting hedgehog signaling.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Leydig cell tumors in the ovary can cause high testosterone and male traits in postmenopausal women but are treatable with surgery.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Surgical removal of a scalp keratoacanthoma is effective and prevents recurrence, but hair may not regrow.

Some skin tumors from hair follicles and glands can be linked to genetic syndromes and may be benign or malignant.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Anti-TNF therapy can cause hair loss and skin issues.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Fluorescent proteins help visualize and understand tumor blood vessel growth.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

The type of tumor suppressor gene lost affects the behavior of skin cancer.